Monday, October 5, 2026

Flow Traders Deploys Deep Learning Unit as Crypto Platforms Build AI Trading Infrastructure

Flow Traders launched a dedicated deep learning initiative in 2025 as part of systematic AI integration across crypto trading platforms. The infrastructure buildout coincides with exchanges like BitMart developing comprehensive AI trading tool suites amid tightening regulatory scrutiny.

LM Salvado

March 21, 2026

Flow Traders Deploys Deep Learning Unit as Crypto Platforms Build AI Trading Infrastructure
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Flow Traders established a deep learning team in 2025 to integrate AI capabilities across its trading operations.1 The move reflects broader infrastructure maturation as crypto exchanges and trading firms deploy machine learning systems at scale.

The Amsterdam-based market maker reported the initiative in its full-year 2025 results, signaling institutional adoption of neural networks for trading strategy optimization.1 Flow Traders operates across equity, bond, commodity, and crypto markets with over billions in equity under management.

BitMart and other exchanges are building AI trading tool suites to serve retail and institutional clients. The infrastructure push comes as crypto markets face regulatory pressure, including USDT credit downgrades and China's reaffirmed crypto ban enforcement.

November 2025 delivered harsh market conditions—dubbed "Painvember" by analysts—with Bitcoin dropping from significant capitalhighs to significant capitallows.8 billion in liquidations across exchanges.2 AI trading systems faced their first major stress test during the volatility.

The trading infrastructure evolution parallels compute advances from Google's Gemini 3 Pro release and Meta's reported shift toward tensor processing units. These hardware improvements enable real-time deep learning inference for high-frequency trading strategies that previously required simplified models.

Regulatory frameworks are tightening as AI adoption accelerates. Stablecoin scrutiny intensified after credit rating agencies downgraded USDT, while Chinese authorities reaffirmed bans on crypto trading despite blockchain technology endorsements for enterprise applications.

The bifurcation creates a divide: sophisticated AI-powered trading infrastructure thrives at institutional firms while retail platforms face compliance costs. Flow Traders' deep learning investment positions the firm to capitalize on volatility that challenges less-equipped competitors.

Market observers note the infrastructure phase differs from previous crypto cycles. Rather than speculative token launches, 2025-2026 developments center on trading system architecture, risk management algorithms, and regulatory compliance automation.

The buildout suggests crypto trading is transitioning from retail speculation to institutional infrastructure, with AI serving as the primary differentiator between sophisticated operations and basic exchange services.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]Press releaseGlobeNewswire· January 13, 2026
    BitMart 2025 Annual Review: Building a More Complete Financial Infrastructure to Drive Long-Term Sustainable Growth
  2. [2]Press releaseGlobeNewswire· December 5, 2025
    CoinEx Research November 2025 Report: Painvember's Brutal Reality Check
  3. [3]News articleYahoo Finance· February 12, 2026
    Flow Traders 4Q and FY 2025 Results

In this story

LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com